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ABSTRACT: Phototoxic effects of 6,8 dihalogenated quinolones confers to this type of molecules a 
potential property as photochemotherapeutic agents. Two photodehalogenation processes seem to be in-
volved in the remarkable photoinduced cellular damage. In this context, a new 6,8 dihalogenated quino-
lone 1 (1-methyl-6,8-difluoro-4-oxo-7-aminodimethyl-1,4-dihydroquinoline-3-carboxylic acid) was syn-
thetized looking for improving the phototoxic properties of fluoroquinolones (FQ) and to determine the 
role of the photodegradation pathways in the FQ phototoxicity. With this purpose, fluorescence emissions, 
laser flash photolysis experiments and photodegradation studies were performed with compound 1 using 
1-ethyl-6,8-difluoro-4-oxo-7-aminodimethyl-1,4-dihidroquinoline-3-carboxylic acid (2) and lomefloxa-
cin (LFX) as reference compounds. The shortening of alkyl chain of the N(1) of the quinolone ring  re-
vealed a lifetime increase of the reactive aryl cation generated from photolysis of the three FQ and a 
significant reduction of the FQ photodegradation quantum yield. The fact that these differences were 
smaller when the same study was done using a hydrogen donor solvent (ethanol-aqueous buffer, 50/50 
v/v) evidenced the highest ability of the reactive intermediate arising from 1 to produce intermolecular 
alkylations. These results were correlated with in vitro 3T3 NRU phototoxicity test. Thus, when Photo-
Irritation-Factor (PIF) was determined  for 1 , 2 and LFX using cytotoxicity profiles of BALB/c 3T3 
fibroblasts treated with each compound in the presence and absence of UVA light, a PIF more higher than 
30 was obtained for 1 while the values for 2 and LFX  were only higher than 8 and 10, respectively. 
Thereby, the present study illustrates an approach to modulate the photosensitizing properties of FQ with 
the purpose to improve the chemotherapeutic properties of antitumor quinolones. Moreover, the results 
obtained in this study also evidence that the key pathway responsible for the phototoxic properties asso-





- The reduction in the length of the N(1)-alkyl chain of fluoroquinolones produces an increase in their 
phototoxicity.  
- The phototoxicity enhancement can be understood by the lack of intramolecular reactivity of a carbene 
intermediate with its N(1)-methyl substituent.  
-Photodehalogenation arising from the fluoroquinolone in bulk water is the main pathway involved in the 
phototoxic processes.  
 
 
Keywords. Excited states, fluorescence emission, laser flash photolysis, photodehalogenation process, 
phototoxicity test. 
 
INTRODUCTION     
    Quinolones are “building blocks” with flexible synthetic routes that can be adapted to prepare large 
libraries of bioactive compounds. Since 1962, 4-quinolone-3-carboxylic acid derivatives are widely used 
as antibacterial agents and for tuberculosis treatment.[1, 2] Moreover, during the last few years, structural 
modifications on quinolones have shown that this type of compounds can also display antitumor and/or 
antiviral activities.[3-9] Thereby, both, high activity of these drugs against eukaryotic topoisomerase and 
their relevant toxicity to cultured mammalian cells and in vivo tumor cells,[10] clearly show their potential 
as new anticancer agents. A family of modified quinolones with antitumor activity that reduce all-cause 
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Chart 1. Chemical structure of dihalogenated FQs  
 
 
Interestingly, a recent study reported an enhancement of  the FQ genotoxicity in eukaryotic system by 
UV irradiation,[12] which also confers to these drugs a potential property as photochemotherapeutic 
agents. In this context, phototoxicity and photogenotoxicity have been remarkably detected in dihalogen-
ated quinolones such as fleroxacin (FLX), BAY y3118 (BAY) as well as lomefloxacin (LFX, compound 
used as standard for photomutagenic studies, see structures in Chart 1).[13-21] Consequently, a large 
number of studies concerning the photophysical and photochemical properties of 6,8-dihalogenated FQ  
with and without the presence of biomolecules have been carried out. An unusual photodehalogenation 
of these FQ by heterolysis of their C8–halogen bonds is the key point in the photoinduced biological 
damages. The FQ photosensitivity reactions have been associated with generation of reactive intermedi-
ates in their photodehalogenation processes.[22-28] In fact, two pathways have been proposed to explain 
the photoinduced adverse effects observed for this type of FQ: I) where a aryl radical (FQ(-F).) is gener-
ated from an intermolecular electron transfer between FQ singlet excited state and a complexed electron 
donor biomolecule, II) where an aryl cation with alkylating properties is formed from the heterolytic 
dehalogenation of its FQ triplet excited state (3FQ) (see Scheme 1).[26-28] Interestingly, it has been ob-
served in FQ photodegradation studies that peripheral substituents of FQ skeleton such as  the piperazinyl 
ring and or the N(1) alkyl substituents react with the aryl cation (FQ(-F)+  to give rise photoproducts, 
hindering intermolecular photoreactions with biomolecules or molecular oxygen (see pathway II in 
Scheme 1).[27-28] It has been established that photoallergy is mainly produced from pathway I,[27] how-
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Scheme 1. Proposed mechanisms for photodehalogenation process of 6.8-difluoroquinolones (FQ) 
in presence of biomolecules (BIO). 
 
 
With this background, the aim of the present study is to enhance the phototoxic potential of FQ in order 
to obtain drugs with more photochemotherapeutic properties.  For this purpose it was thought to decrease 
of the FQ peripheral size for improving the efficiency of the intermolecular photoreactions between FQ 
and biomolecules or molecular oxygen via pathway II. Thus, a new tailored 6,8 dihalogenated FQ (1-
methyl-6,8-difluoro-4-oxo-7-aminodimethyl-1,4-dihidroquinoline-3-carboxylic acid (1), see Chart 1) was 
synthesized.  In order to probe this hypothesis it will be combined photophysical and photochemical stud-
ies (fluorescence emissions, time resolved and steady state photolysis) and in vitro cell cultured experi-
ments (3T3 NRU phototoxicity assay) using FQ derivatives with different peripheral substituents (see 
chemical structures in Chart 1). Thus, the selected FQ was the new compound 1, LFX and 1-ethyl-6,8-
difluoro-4-oxo-7-aminodimethyl-1,4-dihidroquinoline-3-carboxylic acid (2).[29] Moreover, it will be 
also evaluated the role of the FQ photodehalogenation pathways in the phototoxic properties associated 
with FQ. 
 
MATERIALS AND METHODS 
 
Materials. Ethyl 6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylate and lomefloxacin (LFX) 
from Sigma Chemical Company (St Louis, MO). Sodium phosphate buffer was prepared from reagent-
grade products using milli-Q water; the pH of the solutions was measured through a glass electrode and 
adjusted with NaOH to pH 7.4. Other chemicals were of reagent grade and used as received. 
    Synthesis of FQ. 1-Methyl-7-dimethy1amino-6,8-difluoro-1,4-dihydro-3-quinolinecarboxylic acid (1). 
To 5.89 g (21.7 mmol) of ethyl 6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylate were added 7.5 
g (2.5 equiv) of K2CO3 and 300 mL of dry DMF. After the mixture was stirred for 30 min at 50 oC, 20 ml 
(ca. 11.0 equiv) of Iodomethane was added. The temperature was raised to 80 oC, and the mixture stirred 
vigorously for 48 h. It was concentrated to dryness and the residue was diluted with dichloromethane and 
rinsed several times with water. It was dried and concentrated to yield a dark oil.  To 2.2 g (7.4 mmol) of 
this material were added AcOH (40 mL) and HCl (20 ml, 3N) and the mixture was heated for 5 h. Dilution 
with water and filtration gave 1.3 g (64 %) of l-methyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinoline-
carboxylic acid.[30] 
To 1.00 g (3.5 mmol) of l-methyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid in 25 
mL of CH3CN was added a solution of 0.55 g (1.0 equiv) of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) 
and 1 ml (1.1 equiv) of dimethylamine in 5 mL of CH3CN. The mixture was refluxed for 4 h and was 
 
stirred at room temperature overnight. Then, the solid was filtered and washed with 20 mL of CH3CN, 10 
mL of 80% aqueous CH3CN, 20 mL of ethanol, and 20 mL of ether to give 1.01 g (75%) of 1 (amorphous 
solid).. 1H NMR [CDCl3, 300 MHz] δ 2.95 (s, 6H) 4.09 (d, 3H, J=14.7 Hz), 7.8 (d, 1H, J=14.7 Hz), 8.60 
(s, 1H). 13C NMR [CDCl3, 75 MHz] δ 42.03, 45.68, 106.27, 107.64, 118.0, 127.06, 134.67, 144.6 (CF, J 
= 270.25 Hz), 149.75, 153.9 (CF, J = 270.25 Hz), 165.21, 175.23. Exact Mass: m/z found 283.0894, 
calculated for C13H13F2N2O3 (MH+) 283.0894. The UV-Vis spectrum of 1 in 2 mM PB aqueous medium 
shows λmax at 280 and 320 nm. 
1-Ethyl-7-dimethy1amino-6,8-difluoro-1,4-dihydro-3-quinoli- 
necarboxylic acid (2). [29] The same procedures above described for 1-methyl-7-dimethy1amino-6,8-
difluoro-1,4-dihydro-3-quinolinecarboxylic acid (1) were employed to obtain 2.  
Emisssion measurements. The FQ samples were prepared at 1mM PB concentrations starting from a 
stock solution of 200 mM PB adjusted at pH 7.4. The pH changes were induced adding different amounts 
of HCl or NaOH (12 M) to the neutral samples. These measurements were performed with a Crison pH-
meter.   
Fluorescence emission spectra were recorded on a Photon Technology International (PTI) LPS-220B 
fluorimeter. The fluorescence quantum yields were determined by comparing the areas under the emission 
curves with that obtained with quinine bisulfate in 1 N H2SO4, a widely used fluoresence standard (ΦFl = 
0.546). Isoabsorptive samples at 310 nm (A310nm = 0.3) were used. All measurements were recorded at 
room temperature using 1 cm pathway quartz cells with 4 mL capacity.  
Phosphorescence spectra were obtained from a Photon Technology International (PTI, TimeMaster 
TM-2/2003) spectrofluorometer equipped with a pulsed Xe lamp. The apparatus was operated in time-
resolved mode, with a delay time of 0.5 ms. For phosphorecence measurements were used similar samples 
to those described to obtain the fluorescence data. 
Singlet-oxygen measurements were performed registering phosphorescence decay traces at 1270 nm 
after laser pulse employing a Peltier-cooled (- 62.8 ºC) Hamamatsu NIR detector operating at 650 V, 
coupled to a computer-controlled grating monochromator. A pulsed Nd:YAG L52137 V LOTIS TII was 
used at the excitation wavelength of 355 nm. The single pulses were of ca. 10 ns duration, and the energy 
was lower than 5 mJ per pulse. The system consisted of the pulsed laser, a 77250 Oriel monochromator 
coupled to the Hamamatsu NIR detector and the oscilloscope connected to the computer. The output signal 
was transferred from the oscilloscope to a personal computer. All measurements were made at room tem-
perature, under air atmosphere, and using deuterated water at pH ca. 7.4 (1mM PB) as solvent in 10 × 10 
mm2 quartz cells with a capacity of 4 mL. The absorbance of the samples was 0.30 at the laser excitation 
 
wavelength. Perinaphthenone in water (singlet oxygen quantum yield (Φ∆) ca. 0.98)[31] was used as 
standard to estimate Φ∆ of each compound by comparing the phosphorescence intensities at 1270 nm. The 
signal was obtained from the average of 50 laser shots. In this context, fresh samples were used each five 
laser shots to obtain the luminescence of singlet oxygen at 1270 nm. 
LFP measurements. A pulsed Nd:YAG SL404G-10 Spectron Laser Systems was used at the excitation 
wavelength of 355 nm. The single pulses were ~10 ns duration and the energy was lower than 10 mJ/pulse. 
The detecting light source was a pulsed Lo255 Oriel xenon lamp. The LFP system consisted of the pulsed 
laser, the Xe lamp, a 77200 Oriel monochromator, an Oriel photomultiplier tube (PMT) system made up 
of a 77348 side-on PMT tube, 70680 PMT housing and a 70705 PMT power supply. The oscilloscope was 
a TDS-640A Tektronix. The output signal from the oscilloscope was transferred to a personal computer. 
   Unless otherwise stated, all samples used were in aqueous solutions at pH 7.4, and the absorbance was 
set at 0.3 at 355 nm. Each sample was deaerated by bubbling N2O in order to remove the solvated electron. 
Spectra and decays were registered from solutions prepared at different pHs by addition of NaOH or HCl 
to the neutral buffered solution.  
   Determination of the quenching rate constants of the intermediates arising from 1 and 2 by sodium 
bromide (NaBr) were carried out using increasing amounts of the quenchers (from 1 to 400 mM) ensuring 
that no changes in the pH were induced. Under these conditions more than 99 % of the light was absorbed 
by the fluoroquinolone. 
To determine every FQ quenching rate constant (kq) the Stern-Volmer equation was applied 
1/τ = 1/τ0 + kq [Q] 
where τ0 is the lifetime of transient species without quencher (Q).  
Irradiation procedures and equipment. Irradiations were performed in a multilamp photoreactor 
equipped with four lamps emitting in the 310-390 nm range (Gaussian distribution), with a maximum at 
350 nm. The photoreactions were performed under anaerobic conditions using FQs (5 x 10-5 M) in 1 mM 
PB aqueous medium and in 2 mM PB/ethanol (50/50). The kinetic studies to determine photodegradation 
quantum yields of 1, 2 and LFX and the generation of their photoproducts were performed taking aliquots 
after 20, 40, 60, 80, 100 and 120 seconds of irradiation. Afterwards, these samples were monitored by 
HPLC on an analytical C18 column (25 x 0.4 cm, mean particle size 5 µm) with flow rate of 0.7 mL/min 
and a mixture of acetonitrile/water/trifluoroacetic acid 50/49.9/0.1 was used as eluent.  
For in vitro phototoxicity assays, the used light source was a photoreactor model LZC-Y equipped with 
14 lamps for top and side irradiation (lamps emitting in the 310-390 nm range with a maximum at 350 
 
nm and  Gaussian distribution. The irradiation was performed through the lid of 96 well-plate and in order 
to avoid overheating, the plates were placed on ice during the irradiation step. 
The corresponding photoproducts were initially identified by UPLC-MS/MS. Briefly, the chromatog-
raphy was performed on an ACQUITY UPLC system (Waters Corp.) with a conditioned autosampler at 
4 °C. The separation was carried out on an ACQUITY UPLC BEH C18 column (50 mm × 2.1 mm i.d., 
1.7 μm). The column temperature was maintained at 40 °C. The analysis was achieved with gradient 
elution using acetonitrile and water (containing 0.01% formic acid) as the mobile phase. The Waters 
ACQUITY™ XevoQToF Spectrometer (Waters Corp.) was connected to the UPLC system via an elec-
trospray ionization (ESI) interface. The ESI source was operated in positive ionization mode with the 
capillary voltage at 3.0 kV. The temperature of the source and desolvation was set at 100 °C and 400 °C, 
respectively. The cone and desolvation gas flows were 100 L h−1 and 800 L h−1, respectively. All data 
collected in Centroid mode were acquired using Masslynx™ software (Waters Corp.). Leucine-enkepha-
lin was used as the lock mass generating an [M+H]+ ion (m/z 556.2771) at a concentration of 500 pg/mL 
and flow rate of 50 μL/min to ensure accuracy during the MS analysis. 
   The photodegradation quantum yields (ΦD) were obtained by comparison with the value reported for 
LFX (ca. 0.55), which was used as actinometer.  
General procedure to identify photoproducts of 1 and 2.      Preparative deaerated irradiations of 1 
and 2 (2 x 10 -3 M) in 2 mM PB/ ethanol (50/50) using the procedure described above were performed to 
isolate their major photoproducts.  Thereby, a solution of 1 (0.283 g in 500 mL of 2 mM PB/ethanol (1/1)) 
was irradiated during 3 h. Subsequently, the photomixture was acidified with HCl (1N) to pH ca. 3 and 
extracted with CH2Cl2 (3 x 25mL). The organic mixture was dried with MgSO4 and concentrated under 
reduced pressure. Analysis of this photomixture using UPLC-MS/MS revealed the formation of photo-
product 1P which shows an exact mass (m/z) found 265.0992, calculated for C13H14FN2O3 (MH+) 
265.0988.  However, this compound was unambiguously assigned after photomixture treatment with (tri-
methylsilyl)diazomethane. where isolation and characterization were done for its methyl ester 1P´ (methyl 
1-methyl-7-dimethy1amino-6-fluoro-1,4-dihydro-3-quinolinecarboxylate). Thus, the photoproduct mix-
ture was treated with 300µL of (trimethylsilyl)diazomethane (TMSCHN2 2.0 M solution in diethyl ether) 
in dichloromethane (10 mL) for this aim. The reaction mixture was stirred under N2 at 40 ̊C during 2h and 
at room temperature overnight. The reaction mixture was neutralized adding water (10 mL) and extracted 
with CH2Cl2 (3 x 25mL). The organic mixture was dried over MgSO4 and concentrated under vacuum. 
Then, this photomixture was submitted to silica gel column chromatography, using 55/30/10/5 of di-
chloromethane/cyclohexane/acetone/ethanol as mobile phase to isolate 25 mg (9 %) of 1P´ (colorless 
gum): 
 
Methyl 1-methyl-7-dimethy1amino-6-Fluoro-1,4-dihydro-3-quinolinecarboxylate (1P´) 1H NMR 
[CDCl3, 300 MHz,] δ 2.95 (s, 6H) 3.75 (s, 3H), 3.87 (s, 3H), 6.40 (d, 1H, J = 6.9 Hz), 7.92 (d, 1H, J=14.7 
Hz), 8.30 (s, 1H). 13C NMR [CDCl3, 75 MHz] δ 40.41, 43.29, 51.99, 101.48, 109.74, 113.58, 121.27, 
137.48, 144.64, 149.20, 151.95 (CF, J = 270.35 Hz), 166.65, 173.12. Exact Mass: m/z found 279.1150, 
calculated for C14H16FN2O3 (MH+) 279.1145. The UV-Vis spectrum of 1P´in 2 mM PB aqueous medium 
shows λmax at 280 and 320 nm. 
Photoproducts 2P1 and 2P2 were directly obtained from a preparative irradiation similar to the de-
scribed for 1 above but using 2 (296 mg in 500 ml of 2 mM PB/ethanol 1/1 solution). Hence, after 3 h of 
the sample irradiation, the photomixture was acidified with HCl (1N) to pH ca. 3 and extracted with 
CH2Cl2 (3 x 25mL). The organic mixture was dried over MgSO4 and concentrated under vacum. After-
wards, photomixture was submitted to silica gel column chromatography, using 55/30/10/5 of dichloro-
methane/cyclohexane/acetone/ethanol as mobile phase to isolate two amorphous solids, 2P1 64 mg (23 
%)  and 2P2 12 mg (5%).  
1,8-(1,2-ethyl)-7-dimethy1amino-6-fluoro-1,4-dihydro-3-quinolinecarboxylic acid (2P1) 1H NMR 
[D2O, 300 MHz] δ 2.80 (s, 6H) 3.55 (t, 2H, J=7 Hz), 4.57 (t, 2H, J=7 Hz), 7.30 (d, 1H, J=15 Hz), 8.25 (s, 
1H). 13C NMR [D2O, 75 MHz] δ 28.19, 42.79, 52.29, 107.39, 107.73, 118.53, 119.06, 125.10, 141.03, 
141.51, 156.30 (CF, J= 272.15 Hz), 173.14, 174.75. Exact Mass: m/z found 277.0988, calculated for 
C14H14FN2O3 (MH+) 277.0981. The UV-Vis spectrum of 2P1 in 2 mM PB aqueous medium shows λmax 
at 280 and 320 nm. 
1-ethyl-7-dimethy1amino-6-Fluoro-1,4-dihydro-3-quinolinecarboxylic acid (2P2) 1H NMR [CDCl3, 
300 MHz] δ 1.45 ((t, 3H, J=6.8 Hz), 3.05 (s, 6H) 3.75 (s, 3H), 4.22 (c, 2H, , J=6.8 Hz), 6.45 (d, 1H, J=6.9 
Hz),  7.84 (d, 1H, J=15.2 Hz), 8.50 (s, 1H). 13C NMR [CDCl3, 75 MHz] δ 14.26, 42.21, 49.20, 100.80, 
107.83, 112.65, 118.08, 137.42, 145.72, 146.88, 151.65 (CF, J= 270.35 Hz), 167.41, 176.64. Exact Mass: 
m/z found 279.1134, calculated for C14H16FN2O3 (MH+) 279.1145. The UV-Vis spectrum of 2P2 in 2 mM 
PB aqueous medium shows λmax at 280 and 320 nm. 
In Vitro 3T3 neutral red uptake (NRU) phototoxicity test. BALB/c 3T3 fibroblasts cell line was 
grown in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 4 mM glutamine, 1% peni-
cillin/streptomycin 10%  and Fetal Bovine Serum (FBS) and routinely maintained in exponential growth 
in 75 cm2 plastic flasks in a humidified incubator at 37 °C under 5% carbon dioxide atmosphere. The 3T3 
Neutral Red Uptake Phototoxicity Test was performed as described by the OECD guideline 432 (OECD, 
2004) with minor modifications.[32, 33] Briefly, two 96-wells plates (2.5 × 104 cells/well) were seeded 
for each compound. Cells were treated with compounds LFX, 1 2 and SDS at several concentrations 
ranging from 0.5 μM to 500 μM and incubated for 1 h. Afterwards, one plate was irradiated on ice for 
 
11 min to achieve a dose of UVA equivalent to 5 J/cm2 (UVA LIGHT), whereas the another plate was kept 
in a dark box (DARK). The viability of UVA-treated control cells in the absence of test compounds was 
> 90% of those kept in the dark indicating the suitability of the UV dose. After irradiation the compound 
solutions were replaced with DMEM medium, and plates were incubated overnight. Subsequently, neutral 
red solution (50 μg/mL) was added into each well and incubated for 2 h. Cells were washed with PBS and 
neutral red was extracted in 100 μL with the desorbs solution (water 49% (v/v), ethanol 50% (v/v) and 
acetic acid 1% (v/v). Then, the absorbance was measured at 550 nm on a Multiskan Ex microplate reader. 
For each compound dose-response curves were established in order to determine the concentration of 
compound producing a 50% reduction of the neutral red uptake (IC50) in the dark and light. In the end, 
Photo-Irritation-Factor (PIF) was determined using the following equation:  
PIF = IC 50 DARK/IC 50 UVA LIGHT   
According to the OECD Test Guideline (OECD, 2004)[33] a chemical is predicted as phototoxic if PIF is 
> 5, probably phototoxic if PIF > 2 and < 5, and non-phototoxic when PIF < 2. Sodium dodecyl sulphate 
(SDS) was used as negative control and lomefloxacin (LFX) was used as a stablished phototoxic reference 
compound. [19, 21]  
Cellular localization studies by confocal microscopy.  Firstly, FSK cells were seeded on glass co-
verslips in 24 well-plates (5.0 x 104 cells/well). Next day, DMEM medium was replaced by 500 µL of 
compound solutions (LFX, 1 and 2) at 200 µM and incubated for 2 h at 37ºC. Then, coverslips were 
washed once for 5 min with PBS and finally mounted using Mowiol. Microscopy and imaging were per-
formed with a Leica SP5 confocal microscope (Leica, Germany) using sequential mode. Representative 












Absorption spectra of fluoroquinolones 1 and 2. The absorption spectra of 1 and 2 showed almost 
identical UV-Vis spectral features between them (see Figure 1). Nevertheless, in the case of LFX, although 
its absorption maxima were also similar to those of 1 and 2, some changes can be observed, indicating 
that some photophysical properties of the quinolone chromophore change by the presence of a piperazinyl 
ring.  
































Figure 1.  Absorption (left) and fluorescence (right) of compound 1, 2 and LFX (4 x 10-5 M) in 2 mM PB 
aqueous medium. Inset: Phosphorescence of 1 in aqueous medium at 77 K. The emission measurements 
were performed at the excitation wavelength of 310 nm. 
 
Emission measurements of fluoroquinolones 1 and 2.  Fluorescence spectrum of LFX under neutral 
conditions (1 mM PB aqueous medium, pH ca. 7.4) showed an emission band with a maximum at 415 
nm as described in the literature.[22] However, the fluorescence spectra of 1 and 2 display bands at λmax 





















(ΦFl) of 1 and 2 resulted to be markedly lower than that described for LFX (ΦFl ca. 0.08) but their emission 
lifetimes were similar (Table 1).   
 
Table 1. Emission and photochemical properties of LFX, 1 and 2 in aqueous media. 
 aFl bPh cΦD 
FQ λmax 
nm 






LFX 415 0.080 1.3 480 0.55  
1 445 0.008 1.2 480 0.40 0.62 
2 455 0.008 1.3 480 0.75 0.76 
aIn aqueous medium. bIn frozen buffered aqueous media at 77 K.                           
cPhotodegradation quantum yields were determined taking as standard LFX in water (ΦD = 0.55, Ref 25). 
 
    When phosphorescence measurements of 1, 2 and LFX were performed in frozen buffered aqueous 
media at 77 K, their emission spectra resulted to be almost identical (see inset Figure 1 for phosphores-
cence of 1). Thus, a triplet energy ca. 273 kJ/mol  was determined for the three compounds. 
   The decay traces of singlet-oxygen (1O2) phosphorescence at 1270 nm generated by pulsed-laser 
irradiation at 355 nm of aerated deuterated aqueous neutral solutions (1 mM PB aqueous medium, pH ca. 
7.4) of LFX, 1, 2  and perinaphthenone as reference were recorded to determine 1O2 quantum yield (Φ∆) of 
these FQs. The values obtained revealed Φ∆ for LFX, 1 and 2 lower than 0.005. The result obtained for 
LFX is not completely in agreement with the value described in the literature (Φ∆ ca. 0.07 in buffered 
deuterated water).[34] However, as photodegradation quantum yield (ΦD) of LFX  is very high (ΦD = 
0.55) [25], the value described could have increased due to 1O2 generation from photoproducts generated 
during the measurements. In fact, we observed that it was needed to use several fresh samples during the 
acquisition of the value of each dihalogenated fluoroquinolone. 
Laser flash photolysis studies (LFP) of fluoroquinolones 1 and 2.  
Laser flash photolysis of 1 and 2 were carried out in buffered water (1 mM PB) under different atmos-
pheres using LFX as reference compound. Thus, LFX under N2O atmosphere at pH = 7.4 showed the 
presence of an aryl cation with λmax 480 nm and a lifetime (τ) of 250 ns, data very similar to those de-
scribed in the literature.[22, 24]  When the experiments were performed using 1, an intermediate absorb-
 
ing also at λmax 480 nm was also detected (see Figure 2). However, this intermediate showed longer life-
time (τ  ca. 3.1 µs) than the observed for LFX. A reactivity study using molecular oxygen was performed 
in order to determine the nature of the intermediate arising from photolysis of 1. The fact that the presence 
of molecular oxygen up to 2 x 10-3 M did not show any effect on the intermediate lifetime discards a 
triplet excited state nature. Hence, to achieve an unambiguous assignment of this transient species, com-
pound 1 was submitted to LFP in the presence of a nucleophilic anion such as Br-. The efficient quenching 
by Br- showed a rate quenching constant of 1.5 x 1010 M-1 s-1, a value very close to those reported for aryl 
cations generated from LFX and other dihalogenated FQ such as BAY y3118 or fleroxacin.[23, 35]   




















Figure 2. Transient absorption spectra of 1 (10-4 M) in aqueous 1 mM PB in N2O atmosphere at different 
times after the 355 nm laser excitation. Inset: Decay traces at 470 nm of 1 under the same conditions in 
the presence of different concentrations of Br- anion.   
 
    Interestingly, LFP assays using 2 in aqueous solutions showed two consecutive transient species (see 
Figure 3). The first one displayed an absorption spectrum with a λmax 470 nm with a τ  <  300 ns and the 
second one  at λmax 460 nm and a τ  980 ns. It was observed that the two bands were not appreciably 
quenched or modified by the presence of O2 atmosphere, whereas they were affected by the presence of 
the Br- anion. Apparently, the first intermediate seems to be reactive to the anion while the second one 
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decreases its absorbance (see inset of Figure 3). Thereby, the structure of the first transient species would 
be attributed to an aryl cation (FQ(-F)+) similar to the describe for most of the dihalogenated FQ including 
1. The assignment of the second one could be a diradical cation (FQ(-F)¨+) arising from the first interme-
diate (see Scheme 1) as it has previously been proposed in the photolysis of N-acetylated LFX.[22]  
In this context, highlight the absence of any detectable triplet excited state corresponding to the FQs, 
which is in agreement with the almost inappreciable detection of 1O2 for these compounds. 
























Figure 3. Transient absorption spectra of 2 (10-4 M) in aqueous 1 mM PB in N2O atmosphere at different 
times after the 355 nm laser excitation. Inset: Decay traces at 450 nm of 1 under aerobic condition with 
and without the presence of Br- anion.  
 
When the LFP of 1, 2 and LFX were carried out under N2 atmosphere, besides detecting the same tran-
sient species with similar lifetimes than in the experiments performed in N2O, an intermediate absorbing 
at λmax ca. 720 nm was observed. The spectrum absorption shape and the high quenching rate constant by 
oxygen and N2O (> 109 M-1 s-1) supports its assignment as the solvated electron. In fact, this intermediate 
has been observed in neutral aqueous medium by excitation at 355 nm through a two-photon process 
under moderate laser energy conditions in all FQ studied under similar conditions. [23, 36-38]. In this 
context, in agreement with the literature,[22-28] the solvated electrons detected under N2 or the hydroxyl 
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radicals generated from the reaction of solvated electrons with N2O do not seem to modify the lifetime of 
the detected intermediates. 
 
Photodegradation studies. Irradiations of 1 and 2 in deaerated aqueous solutions at pH ca. 7.4 using 
LFX as reference compound were performed in a multilamp photoreactor using UVA light at λmax = 350 
nm. Kinetics studies showed different photodegradation quantum yields (ΦD) for 1, 2 and LFX (Table 1). 
Analysis of the photoreactions revealed a photodegradation quantum yield (ΦD) of 0.4 for 1 but only small 
amount of photoproducts were detected being the major photoproduct with 1P with a formation quantum 
yield (ΦPF) lower than 0.02 (see structure in Scheme 2).  Thereby, a photopolymerization process justifies 
the high ΦD of 1. Interestingly, photolysis of 2 showed the highest ΦD giving rise mainly 2P1 (ΦPF 0.75) 
and small amounts of 2P2 (ΦPF of 0.05) (see Scheme 2). In this context, significant changes were observed 
when the photodegradation of 1 was carried out using a hydrogen donor media such as a mixture of eth-
anol/water (2 mM PB) 1/1. In fact, ΦD of 1 increased to 0.62 and the ΦPF of its photoproduct 1P growths 
up 0.20. By contrast, ΦD of 2 did no appreciably change in the aqueous alcoholic medium (ΦD = 0.76) 
although ΦPF of its photoproducts was modified (ΦPF of 0.70 and 0.14 for 2P1 and 2P2 respectively). The 
structures of 1P, 2P1 and 2P2 were unambiguously assigned using the spectroscopic data, which are listed 

















































































Phototoxic properties. Cell viability upon incubation with LFX, 1 and 2 in combination with UVA light 
was assessed by the in vitro 3T3 NRU phototoxicity test. Thus, cytotoxicity profiles of BALB/c 3T3 
fibroblasts treated with LFX, 1 and 2 were measured in the presence and absence of UVA light, using 
neutral red as vital dye and half maximal inhibitory concentration (IC50) were determined from dose-
response curves. More details are provided in Supplementary material. 
This test is based on the calculation of the Photo-Irritation-Factor (PIF) that corresponds to the ratio of 















LFX > 500 50 ±8 > 10 
1 > 500 16±9 > 30 
2 > 500 65±26 > 8 
SDS 220±21 244±25 1 
Data represent mean ±SD from four independent experiments. LFX and SDS were used as positive and negative controls of 
phototoxicity, respectively. 
















Figure 4. Data represent the Photo-Irritation-Factor (PIF) determined using the equation PIF=IC50 
DARK/IC50 UVA LIGHT. The IC50 were determined from the 3T3 NRU assay. 3T3 cells were treated 
with serial dilutions of LFX, 1 and 2 ranging from 0.5 μM to 500 μM for 1 h, followed by irradiation (or 
not) with a dose of 5 J/cm2 UVA light. LFX and SDS were used as positive and negative control of pho-
totoxicity, respectively.[33, 39] After 24 h cell viability was determined by neutral red uptake and IC50 
values were calculated by non-lineal regression with GraphPad Prism 5.0.   
 
As shown in Table 2 and Figure 4, LFX was clearly phototoxic as anticipated (PIF ca. 10). For 2 a toxicity 
with a PIF of ca. 8 was obtained. Interestingly, the effect observed for 1 resulted to be higher than LFX 
and 2 (a 3-fold increase of the IC50 was determined, PIF ca. 30). Noteworthy, only, 1 displays a N(1) 
methyl substituent. Hence, the different behavior shown in phototoxic assays may be modulated by the 
N-alkyl chain of the fluoroquinolones. However, as FQ location in cells could modify the biomolecules 
photodegradation and, consequently the phototoxicity, intracellular localization of LFX, 1 and 2 in FSK 
cells was performed by confocal microscopy.  Interestingly, as shown in Figure 5, similar cytoplasmic 
distribution is observed for all compounds (blue emission), indicating that the higher phototoxicity of 1  relative 




Figure 5. Confocal microscopy images of intracellular localization of LFX (A), 1 (B) and 2 (C) in FSK 
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The photophysical, photochemical and photobiological properties found for 1 and 2 together with those 
described in the literature for other dihalogenated FQ [22-28, 33] were analyzed to rationalize the possible 
mechanisms involving the photosensitized cell damage produced by the dihalogenated FQ 1 and 2.  
Initially, as the UV-induced biomolecules damage in the presence of FQs can involve a triplet-triplet en-
ergy transfer reaction, photosensitized generation of 1O2 and radicals generation from FQ photodehalo-
genation,[13,40] all of them would be evaluated to determine the mechanisms responsible for the photo-
toxic properties associated with the dihalogenated quinolones. However, the lack of detection of any tri-
plet excited state for LFX, 1 and 2 in the laser flash photolysis experiments and the almost unappreciable 
singlet oxygen generation from the three dihalogenated quinolones clearly evidence that the photodehalo-
genation of these FQs is their major process to produce the biological damage. The apparent inconsistency 
between the lack of detection of LFX triplet excited state and the described LFX-photosensitized for-
mation of cyclobutane dimers in cellular DNA,[40] which must be occur via a triplet-triplet energy trans-
fer mechanism, [41] could be understood through the LFX photoproducts participation  because the pho-
todehalogenation is a high efficient process for LFX. In fact, this also explain why a 1O2 generation quan-
tum yield of 0.07 had been described for LFX.[34] Thereby, the main pathways involving photodehalo-
genation of LFX, 1 and 2 are shown in Scheme 3. As previously shown in Scheme 1 for LFX and other 
dihalogenated quinolones,[26-28]  the most relevant photosensitization processes associated with dihalo-
genated FQ including compound 1 and 2 can be understood from photodehalogenation pathways I and II. 
However, the results obtained in this study have evidenced that the reactions arising from II must be the 
key processes in the FQ photosensitized cell damage. In this context, photophysical and photochemical 
properties of 1, 2 and LFX were compared to determine the effects of peripheral substituents such as the 
N(1)alkyl or the piperazinyl ring. Thus, although most of the photophysical properties of 2 are quite dif-
ferent to that of LFX (see Fig. 1 and Table 1), photodegradation of aqueous solutions of 2 mainly gives 
rise photoproduct 2P1 (see via IIa in Scheme 3), a tricyclic compound similar to the main photoproduct 
of LFX.[26-28] An intramolecular hydrogen abstraction reaction between the aryl carbene of 2 and its 
N(1)ethyl group initiates a cyclization route  to form  2P1 (intermediates involving this process are shown 
in Scheme 2). By contrast, photoproduct analysis of the irradiation of 1 revealed the inability of the aryl 
carbene FQ(-F-): of 1 to react with its N(1)-methyl substituent. These results can be correlated with the 
results of laser flash photolysis experiments, where the detected aryl cations arising from 1 and 2 showed 
important differences in the generation and lifetime of their aryl cations (see Fig. 2 and 3). Hence, a fast 
 
intramolecular rate constant between a carbene FQ(-F-): and its N(1)-ethyl substituent can justify the ob-
served decrease in the generation and lifetime of the aryl cations arising from 2 and also from LFX. 
Thereby, the longer lifetime of the aryl cation of 1 produces an efficiency growth of the intermolecular 
reactions of this intermediate with its released fluorine anion (via IIc, which clarifies the lower photodeg-
radation quantum yield of 1 than that of 2 or LFX under the same conditions (Table 1)) or with 1 ground 
states (via IIb, which can be the first step of a polymerization process). In this context, pathway IIb can 
also explain the degradation changes observed in the photolysis of 1 and 2 when they were performed 
using a hydrogen donor solvent such as ethanol (see results in Table 1). Thus, the presence of high amounts 
of hydrogen donor molecules in the photoreaction media produce a reaction increase of the aryl carbene 
FQ(-F-):  generated from 1 or 2 with ethanol, which improves the formation of photoproduct 1P or 2P2, 
respectively.  By contrast, the efficiency of the other hydrogen abstraction processes is reduced. Hence, 
the presence of ethanol in the photodegradation of 1 also produces a decrease of the intermolecular reac-
tions of the aryl carbene FQ(-F-):  with its ground state (see via IIb in Scheme 3) and with fluoride anion 
via IIc (Scheme 3). Consequently a low photopolymerization of 1 and a growth of its photodegradation 
quantum yield (see Table 1), respectively, is observed. In the case of 2, as its intermolecular reactions of 
via IIb competes mainly with the intramolecular pathway IIa (see Scheme 3), the ethanol presence reduces 
amounts of 2P1.  
These findings resulted to be relevant to understand the cellular damage photoinduced by FQ when in 
vitro 3T3 NRU assays were performed. Thus, a clear correlation between the photodehalogenation process 
of route II and phototoxic effects in cultured cells was found (see Figure 4 and Table 2). The highest 
phototoxicity produced by 1 in presence of fibroblast cells seems to indicate that the main pathway in-
volved in its phototoxicity is pathway II because only this route can be influenced by the reactivity of the 
N(1)-alkyl chain of FQ (Scheme 2 and 3). Intermolecular reactions between biomolecules and the inter-
mediates arising from FQ dehalogenation are the main processes involved in the phototoxicity of 1 (see 
pathways IIb and IId in Scheme 3), however for 2 and LFX, annihilation of their aryl carbenes by coupling 
of them with their N(1)-ethyl groups is an efficient process competing with pathways IIb and IId. The 
interpretation of the findings could be incorrect if the cellular location of 1, 2 and LFX was different 
because this fact could modulate the biomolecules photodegradation and consequently the phototoxic 
effects. Interestingly, as shown in Figure 5, similar cytoplasmic distribution is observed for all compounds 
(blue emission), indicating that the higher phototoxicity of 1  relative to LFX and 2 can not be attributed 





A new FQ (1) with a N(1)-methyl group has been synthesized, the reduction in the length of the N(1)-
alkyl chain of FQ reveals significant changes in the FQ photodehalogenation processes. Thus, an increase 
in the generation efficiency and lifetime of a reactive intermediate is observed and the photoproducts 
formation is also modified. Besides, the results of in vitro 3T3 NRU assays revealed a higher phototoxicity 
for 1 than those with longer a N(1)-alkyl chain.  All the results can be understood by the lack intramolec-
ular reactivity of a carbene intermediate with its N(1)-methyl substituent. Moreover, the higher phototox-
icity for 1 also confirms that the photodehalogenation arising from the free FQ (in bulk water) is the main 
pathway involved in the phototoxic processes. This study provides a way for tuning the phototoxicity of 
FQ, which could be used to enhance this adverse effect as a photochemotherapeutic property to improve 
their antitumor activity.  
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